Bertagnolli’s Push For Trial Reforms, Data Sharing Aligns With FDA

National Institutes of Health Director-nominee Monica Bertagnolli’s decades-long work to help reform the U.S. clinical trial enterprise, including in the cancer space, and enhance data-sharing across the research community likely will be a boon to the Biden administration, and especially FDA, according to HHS and advocates, as the agency works to increase diversity in clinical trials, streamline trial designs, break down currently existing data silos and meet the goals of the Cancer Moonshot program. Bertagnolli, who has served as director...